| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥805.7B | ¥736.7B | +9.4% |
| Operating Income | ¥42.2B | ¥22.3B | +89.4% |
| Ordinary Income | ¥52.3B | ¥36.3B | +44.2% |
| Net Income | ¥41.5B | ¥32.1B | +29.2% |
| ROE | 4.6% | 3.8% | - |
FY2025 consolidated results: Revenue 805.7B yen (YoY +9.4%), Operating Income 42.2B yen (YoY +89.4%), Ordinary Income 52.3B yen (YoY +44.2%), Net Income 41.5B yen (YoY +29.2%). Operating margin improved to 5.2% from 3.0% YoY, driven by revenue growth and cost control. Profitability metrics show significant improvement with ROE of 4.6%, although total asset turnover declined to 0.52x from prior 0.51x. Operating cash flow of 71.5B yen (1.58x net income) demonstrates strong cash generation capacity. The company recorded extraordinary gains including 6.7B yen from sale of investment securities and 3.5B yen foreign exchange gains, which contributed to earnings growth. Full-year guidance projects revenue of 885.0B yen (+9.8% YoY) and operating income of 55.0B yen (+30.2% YoY), indicating continued growth trajectory.
Revenue increased 68.9B yen to 805.7B yen, representing 9.4% YoY growth. Machine Tool Operations segment led the growth with revenue of 585.4B yen, capturing 72.6% of total revenue. Industrial Machinery Operations contributed 98.4B yen (12.2% of total) while Food Processing Machinery Operations generated 69.5B yen (8.6% of total). Revenue growth was primarily driven by recovery in capital investment demand across key markets and favorable foreign exchange effects, with FX gains of 3.5B yen recorded in non-operating income.
From a profitability perspective, gross profit margin improved to 35.0% from prior year's estimated 32.5%, reflecting better product mix and operational efficiency. Operating income surged 19.9B yen to 42.2B yen, with operating margin expanding 2.7 percentage points to 5.2%. SG&A expenses increased to 239.8B yen (29.8% of revenue) from prior 214.6B yen, but the ratio declined from 29.1%, indicating effective cost management despite growth investments. R&D expenses of 23.4B yen (2.9% of revenue intensity) support ongoing product development.
Non-operating income contributed 10.1B yen net, comprising interest income of 3.4B yen, dividend income of 1.2B yen, equity method income of 3.3B yen, and foreign exchange gains of 3.5B yen. Extraordinary items included 13.4B yen in extraordinary income (primarily 6.7B yen gain on sale of investment securities) offset by 7.8B yen in extraordinary losses (including 5.7B yen restructuring costs). These non-recurring factors added approximately 5.6B yen to pre-tax profit.
The performance pattern is revenue up/profit up, with revenue growth of 9.4% accompanied by operating income growth of 89.4%, demonstrating strong operational leverage and margin expansion.
Machine Tool Operations delivered revenue of 585.4B yen with operating income of 54.6B yen, achieving a segment margin of 9.3%. This segment represents the core business with 72.6% revenue share and demonstrated strong profitability recovery. Operating income increased from prior year's 34.5B yen (estimated from segment data), reflecting improved capacity utilization and pricing power in electrical discharge machines and machining centers.
Industrial Machinery Operations generated revenue of 98.4B yen with operating income of 5.2B yen, resulting in a 5.3% margin. This segment focuses on plastic injection molding machines and experienced modest growth with revenue increasing from 95.6B yen YoY. The margin compression compared to Machine Tool Operations reflects different competitive dynamics in the industrial machinery market.
Food Processing Machinery Operations recorded revenue of 69.5B yen with operating income of 9.8B yen, achieving the highest segment margin of 14.1%. Revenue declined from 76.9B yen YoY, but the segment maintained strong profitability through noodle manufacturing plants and equipment. The margin differential of 4.8 percentage points above Machine Tool Operations reflects specialized product positioning and limited competition in niche food processing equipment markets.
[Profitability] ROE of 4.6% represents improvement from prior year's estimated 3.8%, though remains below typical manufacturing industry benchmarks of 8-10%. Operating margin of 5.2% expanded 2.7 percentage points from 3.0% YoY, reflecting operational leverage benefits. Net profit margin reached 5.1% compared to prior 4.4%, supported by both operating improvements and non-recurring gains. Gross margin of 35.0% improved from estimated 32.5%, indicating favorable product mix and pricing environment. [Cash Quality] Cash and deposits of 450.6B yen increased 58.4B yen from 392.2B yen, with short-term investment securities of 40.0B yen providing additional liquidity of 490.6B yen total. Cash coverage of short-term debt stands at 11.2x, demonstrating exceptional liquidity position. Operating cash flow of 71.5B yen represents 1.58x net income, confirming strong cash generation quality. [Investment Efficiency] Total asset turnover of 0.52x remained relatively stable from 0.51x, constrained by working capital accumulation. Days Sales Outstanding increased to 88 days from 77 days, while Days Inventory Outstanding expanded to 233 days from 201 days, resulting in Cash Conversion Cycle extending to 274 days from 245 days. This working capital deterioration warrants attention as it reflects delayed cash recovery despite revenue growth. [Financial Health] Equity ratio of 58.2% improved from 58.2% YoY, maintaining conservative capital structure. Current ratio of 286.7% increased from 272.4%, indicating strengthened short-term liquidity. Debt-to-equity ratio of 0.23x (interest-bearing debt of 209.3B yen against equity of 905.9B yen) remains well within prudent leverage levels.
Operating cash flow of 71.5B yen decreased 28.3% YoY from 99.7B yen, despite net income growth, primarily due to working capital buildups. Operating CF represents 1.58x net income, indicating solid earnings quality with cash backing. The operating CF subtotal before working capital changes reached 75.5B yen. Working capital movements consumed cash through receivables increase of 20.0B yen and inventory accumulation of 4.0B yen, partially offset by payables increase of 2.0B yen. Contract liabilities increased 19.3B yen, providing positive cash contribution from advance customer payments. Income taxes paid totaled 16.4B yen while interest and dividends received contributed 8.4B yen inflow. Investing cash flow of negative 39.5B yen comprised primarily CapEx of 20.9B yen, representing 2.6% of revenue and 60.8% of depreciation (34.4B yen), suggesting conservative investment posture. Financing cash flow of negative 24.8B yen reflected dividend payments and share repurchases of 1.8B yen, demonstrating balanced capital allocation. Free cash flow of 31.9B yen (operating CF minus investing CF) provides 2.01x coverage of dividends, confirming dividend sustainability.
Ordinary income of 52.3B yen versus operating income of 42.2B yen demonstrates net non-operating contribution of approximately 10.1B yen, equivalent to 1.3% of revenue. This comprises interest income of 3.4B yen, dividend income of 1.2B yen, equity method income of 3.3B yen, and foreign exchange gains of 3.5B yen as primary positive components, offset by interest expense of 4.2B yen. Non-operating income represents 2.3% of revenue, with the FX gains being variable in nature. Extraordinary items materially impacted earnings with gains on sale of investment securities of 6.7B yen and other extraordinary income totaling 13.4B yen, offset by restructuring costs of 5.7B yen and other extraordinary losses of 7.8B yen, resulting in net extraordinary gain of 5.6B yen. These non-recurring factors contributed approximately 9.7% to pre-tax profit of 57.9B yen, warranting adjustment for normalized earnings assessment. Operating cash flow of 71.5B yen exceeding net income of 41.5B yen by 1.58x indicates healthy core earnings quality, though working capital efficiency deterioration (DSO extending to 88 days, DIO to 233 days) requires monitoring. The accrual component appears reasonable with depreciation of 34.4B yen and goodwill amortization of 2.3B yen representing non-cash charges properly reflected in cash flow reconciliation.
Full-year guidance projects revenue of 885.0B yen, operating income of 55.0B yen, ordinary income of 60.0B yen, and net income of 51.0B yen. Current period results represent 91.0% progress rate for revenue (805.7B yen / 885.0B yen), 76.8% for operating income (42.2B yen / 55.0B yen), 87.2% for ordinary income (52.3B yen / 60.0B yen), and 81.4% for net income (41.5B yen / 51.0B yen assuming parent attribution). Revenue progress rate of 91.0% exceeds typical full-year completion rate of 100%, suggesting actual results have surpassed original full-year guidance by approximately 885.0B yen, indicating the guidance likely represents a revised or conservative baseline. Operating income progress of 76.8% aligns reasonably with expected completion trajectory, though quarterly seasonality may concentrate remaining 23.2% in final reporting periods. The guidance implies Q4 revenue of approximately 79.3B yen and operating income of 12.8B yen to achieve targets. Contract liabilities of 58.2B yen provide forward revenue visibility equivalent to 6.6% of annual revenue guidance, representing approximately 24 days of revenue backlog. No significant guidance revision was disclosed in the current period data, suggesting management maintains confidence in achieving stated targets despite working capital pressures and operational execution requirements in remaining periods.
Annual dividend of 29.0 yen per share comprises interim dividend of 14.0 yen and year-end dividend of 15.0 yen, reflecting stable distribution policy. The dividend increased from prior year's total of 26.0 yen (estimated from payout ratio context), representing 11.5% YoY growth. Payout ratio of 35.7% (based on reported data) against net income indicates conservative dividend policy with substantial retention for growth investment. Dividend coverage by free cash flow stands at 2.01x (FCF of 31.9B yen versus estimated total dividends of approximately 15.9B yen based on outstanding shares), confirming strong dividend sustainability. Share repurchases of 1.8B yen were executed during the period, contributing to total shareholder returns. Total return ratio combining dividends and buybacks reaches approximately 42.3% of net income (estimated as (15.9B + 1.8B) / 41.5B), demonstrating balanced approach between shareholder returns and business reinvestment. Full-year dividend forecast of 20.0 yen suggests conservative guidance that may be subject to upward revision given actual performance trends and cash generation capacity.
Working capital efficiency deterioration poses material cash flow risk with Days Sales Outstanding extending to 88 days from 77 days YoY and Days Inventory Outstanding expanding to 233 days from 201 days. This 29-day lengthening of Cash Conversion Cycle to 274 days from 245 days indicates delayed cash recovery of approximately 20.0B yen in receivables and 4.0B yen in inventory buildup. Continued deterioration could constrain operational flexibility and require increased external financing despite strong cash position.
Capital investment insufficiency presents medium-term competitive risk with CapEx-to-depreciation ratio of 60.8% (20.9B yen CapEx against 34.4B yen depreciation). This under-investment relative to asset consumption may compromise manufacturing capacity expansion, technology renewal, and product development capabilities necessary to sustain market position in precision machinery markets. Three consecutive years of similar patterns would signal systematic underinvestment requiring correction.
Goodwill and intangible asset impairment risk increased materially with goodwill surging 391% to 35.1B yen from 7.1B yen and total intangible assets expanding 146.8% to 54.8B yen from 22.2B yen. These acquisitions totaling approximately 60B yen require successful integration and performance achievement to avoid future impairment charges. Annual goodwill amortization of 2.3B yen represents 6.6% of current goodwill balance, implying 15-year amortization period, though impairment testing could trigger accelerated write-downs if acquired businesses underperform.
[Industry Position] (Reference - Proprietary Analysis)
Operating margin of 5.2% positions below typical precision machinery and machine tool manufacturers' median operating margins of 7-10%, indicating room for margin improvement through operational efficiency gains and product mix optimization. The significant 89.4% YoY operating income growth demonstrates recovery trajectory toward industry norms following prior year's depressed profitability. ROE of 4.6% remains below manufacturing industry median of 8-10%, reflecting conservative capital structure (58.2% equity ratio) and moderate return on invested capital. Debt-to-equity ratio of 0.23x compares favorably against industry median of 0.40-0.60x, indicating conservative financial leverage that provides flexibility for strategic investments or economic downturns. The company's working capital cycle of 274 days significantly exceeds typical precision machinery manufacturers' 180-220 day range, highlighting competitive disadvantage in operational efficiency. Revenue growth of 9.4% YoY aligns with industry recovery patterns following capital investment cycle trough, though sustainability depends on global manufacturing capex trends and semiconductor equipment demand. Contract liabilities representing 7.2% of revenue (58.2B yen / 805.7B yen) provide modest forward visibility compared to build-to-order manufacturers maintaining 15-25% advance payment ratios.
※ Industry: Precision Machinery & Machine Tool Manufacturing, Comparison: Prior fiscal periods and industry norms, Source: Proprietary analysis
Strong operating leverage demonstrated by 89.4% operating income growth against 9.4% revenue growth indicates significant margin expansion potential as fixed cost absorption improves with volume recovery. Operating margin expansion of 2.7 percentage points to 5.2% from structural cost improvements and favorable product mix suggests pathway toward industry-standard 7-10% margins over medium term if revenue momentum sustains and operational efficiency programs deliver results.
Working capital management deterioration represents key earnings quality concern with Cash Conversion Cycle extending 29 days to 274 days, absorbing approximately 24B yen cash that could otherwise strengthen balance sheet or fund growth investments. Days Sales Outstanding increase to 88 days and Days Inventory Outstanding expansion to 233 days indicate systematic challenges in collection efficiency and inventory optimization requiring management attention to unlock trapped cash and improve return on invested capital.
Capital allocation priorities reflect conservative posture with CapEx at 60.8% of depreciation suggesting systematic under-investment in capacity and technology renewal. Combined with goodwill surge of 27.9B yen and intangible assets increase of 32.6B yen totaling approximately 60B yen in acquisition-related assets, management appears to favor external growth over organic capacity expansion. This strategy warrants monitoring for integration success and synergy realization to justify premium paid while ensuring long-term manufacturing competitiveness through adequate organic investment.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.